CYNTHIA SCHREFFLER: Open Payments
NPI 1316577729 · IRWIN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $190 |
| PFIZER INC. | 3 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Viatris Specialty LLC | 1 | $20 |
| Organon LLC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Wegovy, Rybelsus, ZORYVE, SHINGRIX, CAPLYTA, PREVNAR 20, YUPELRI, Ozempic.
Industry payments across PA — which companies pay providers there.
